Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Avricore Health Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by kingposton Jan 04, 2015 9:41pm
175 Views
Post# 23284759

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I'm home

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I'm home
lscfa wrote: Yes, Vanc may convince a pharmacist to make a switch. That is why I am assuming they eventually can grab 5% of the market share. But with an average of 13 competitors for each generic drug Vanc is trying to sell, profit margins will be be small. Thus my assumption of 10%. 



seeling prices are regulated by HC for generics...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities